Unknown

Dataset Information

0

STAT5 induces miR-21 expression in cutaneous T cell lymphoma.


ABSTRACT: In cutaneous T cell lymphomas (CTCL), miR-21 is aberrantly expressed in skin and peripheral blood and displays anti-apoptotic properties in malignant T cells. It is, however, unclear exactly which cells express miR-21 and what mechanisms regulate miR-21. Here, we demonstrate miR-21 expression in situ in both malignant and reactive lymphocytes as well as stromal cells. qRT-PCR analysis of 47 patients with mycosis fungoides (MF) and Sezary Syndrome (SS) confirmed an increased miR-21 expression that correlated with progressive disease. In cultured malignant T cells miR-21 expression was inhibited by Tofacitinib (CP-690550), a clinical-grade JAK3 inhibitor. Chromatin immunoprecipitation (ChIP) analysis showed direct binding of STAT5 to the miR-21 promoter. Cytokine starvation ex vivo triggered a decrease in miR-21 expression, whereas IL-2 induced an increased miR-21 expression in primary SS T cells and cultured cytokine-dependent SS cells (SeAx). siRNA-mediated depletion of STAT5 inhibited constitutive- and IL-2-induced miR-21 expression in cytokine-independent and dependent T cell lines, respectively. IL-15 and IL-2 were more potent than IL-21 in inducing miR-21 expression in the cytokine-dependent T cells. In conclusion, we provide first evidence that miR-21 is expressed in situ in CTCL skin lesions, induced by IL-2 and IL-15 cytokines, and is regulated by STAT5 in malignant T cells. Thus, our data provide novel evidence for a pathological role of IL-2Rg cytokines in promoting expression of the oncogenic miR-21 in CTCL.

SUBMITTER: Lindahl LM 

PROVIDER: S-EPMC5216756 | BioStudies | 2016-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC3735708 | BioStudies
| S-EPMC4653025 | BioStudies
2020-01-01 | S-EPMC7225173 | BioStudies
2016-01-01 | S-EPMC5085149 | BioStudies
1000-01-01 | S-EPMC4558148 | BioStudies
2008-04-09 | E-GEOD-8685 | ArrayExpress
2008-04-09 | E-GEOD-8687 | ArrayExpress
2008-02-19 | GSE8685 | GEO
1000-01-01 | S-EPMC5666818 | BioStudies
1000-01-01 | S-EPMC5790478 | BioStudies